Pfizer Q4 Earnings Preview: Strong top line growth expected on COVID-19 product demand
Pfizer (PFE) is set to announce Q4 earnings, with analysts expecting a $0.46 profit per share and $17.26B revenue.
FiercePharma13h
Pfizer harnesses COVID fluctuations to clinch Q4 gains as RSV vaccine sales plummet
After a period of unsteady sales for its key COVID-19 products, Pfizer now sees COVID-related revenue volatility as “largely ...
Pfizer Shares Fall Despite EPS Soaring 530% in Q4
Pfizer ( PFE, Financial) stock dropped more than 2% at the start of the stock market opening Tuesday after the company posted ...
precisionmedicineonline9h
Pfizer Reports 27 Percent Oncology Growth in Q4, Touts Progress in ADC and Breast Cancer Trials
The firm recorded Q4 oncology revenues of $4.06 billion compared to $3.19 billion in the same period last year.
Pfizer Gears Up For Q4 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts
Analysts expect the New York-based company to report quarterly earnings at 46 cents per share, up from 10 cents per share in ...
Pfizer Shares Rise on Better-Than-Expected 4Q
The positive quarter caps a busy year of cost cutting and pressure from an activist investor as Pfizer has sought to turn around company performance. Shares rose 1.2% to $26.51 soon after market open.